China Universal Asset Management Company’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
31,966
+80
| +0.3% | +$3.16K | 0.12% | 148 |
|
|
2025
Q1 | $962K | Sell |
31,886
-1,594
| -5% | -$48.1K | 0.09% | 190 |
|
|
2024
Q4 | $1.17M | Buy |
33,480
+5,359
| +19% | +$187K | 0.11% | 142 |
|
|
2024
Q3 | $1.13M | Buy |
28,121
+10,971
| +64% | +$439K | 0.12% | 131 |
|
|
2024
Q2 | $817K | Sell |
17,150
-10,877
| -39% | -$518K | 0.12% | 115 |
|
|
2024
Q1 | $1.21M | Buy |
28,027
+11,429
| +69% | +$495K | 0.15% | 112 |
|
|
2023
Q4 | $840K | Buy |
16,598
+12,928
| +352% | +$654K | 0.16% | 119 |
|
|
2023
Q3 | $166K | Buy |
3,670
+1,795
| +96% | +$81.4K | 0.05% | 158 |
|
|
2023
Q2 | $76.9K | Sell |
1,875
-62
| -3% | -$2.54K | 0.02% | 165 |
|
|
2023
Q1 | $69.2K | Buy |
1,937
+494
| +34% | +$17.7K | 0.02% | 142 |
|
|
2022
Q4 | $54.5K | Buy |
1,443
+114
| +9% | +$4.31K | 0.02% | 135 |
|
|
2022
Q3 | $59K | Buy |
+1,329
| New | +$59K | 0.02% | 120 |
|